In a flu pandemic setting, the drug could be used to curb household transmission, especially early in the response, the authors say.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
(CIDRAP News) A new test developed by federal experts offers preliminary detection of H5 avian influenza in human patients in about 4 hours, compared with 2 to 3 days for other methods, government officials announced today.
(CIDRAP News) A pair of new studies suggest that influenza vaccines based on adenoviruses, one of the causes of the common cold, may offer major advantages in the quest for protection from flu pandemics.
(CIDRAP News) – A national conference scheduled Feb 14 and 15 in Minneapolis will give business leaders an opportunity to learn from experts about the risk of pandemic influenza and help figure out how their industries can prepare for it.
(CIDRAP News) Roche announced yesterday it was again shipping its antiviral drug oseltamivir (Tamiflu) to all US markets, lifting restrictions imposed last fall because of concern about people hoarding the drug out of fear of a potential influenza pandemic.
Jan 20, 2005 (CIDRAP News) Researchers who analyzed numerous clinical trials concluded that the two newest antiviral drugs for influenza, oseltamivir (Tamiflu) and zanamivir (Relenza), should not routinely be used against seasonal flua recommendation flatly rejected by the manufacturer of oseltamivir.
(CIDRAP News) The Swiss drug company Roche said today it would give another 2 million treatment courses of its anitivral drug oseltamivir (Tamiflu) to the World Health Organization for developing countries to use to fight avian influenza in humans.
The announcement came as representatives from 90 countries and 20 organizations met in Beijing for a conference to raise funds to battle the H5N1 virus.
(CIDRAP News) The dominant strain of influenza virus in the United States has unexpectedly turned highly resistant to the two older antiviral flu drugs in use, prompting federal health officials today to advise physicians to stop using them for the rest of this season.
(CIDRAP News) The US Food and Drug Administration (FDA) gave its blessing last week to the use of the antiviral drug oseltamivir (Tamiflu) to prevent influenza in children between the ages of 1 and 12.
The FDA had previously approved oseltamivir for treating (but not preventing) flu in that age-group and for both treating and preventing flu in adolescents and adults. Many countries are stockpiling the drug to prepare for a possible flu pandemic.
(CIDRAP News) A new report says oseltamivir-resistant forms of H5N1 avian influenza virus were found in two Vietnamese girls who died of the infection, raising doubts about the antiviral drug that many countries are counting on to help protect them from a potential flu pandemic.
(CIDRAP News) US customs agents have seized more than 50 shipments of fake oseltamivir (Tamiflu), the antiviral drug being stockpiled in preparation for a possible influenza pandemic, according to reports published yesterday.
